Ellie Merle
Analyst, UBS
Replay available
Revolution Medicines, Inc. (RVMD) Q1 2025 Earnings Call
Revolution Medicines, Inc. (NASDAQ: RVMD) Q1 2025 earnings conference call, held 2025-05-07. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Jack Anders
Chief Financial Officer
Dr. Wei Lin
Chief Medical Officer
Eric Joseph
Analyst, JP Morgan
Dr. Mark Goldsmith
Chairman and Chief Executive Officer
Jonathan Chang
Analyst, Leerink Partners
Michael Schmidt
Analyst, Guggenheim
Dr. Steve Kelsey
President of R&D
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Revolution Medicines, Inc..
Replay transcript excerpt
WEBVTT 00:00:01.060 -- 00:00:05.485 Good day, and thank you for standing by. Welcome to the Revolution Medicine's Quarter 00:00:05.485 -- 00:00:10.932 1 2025 Earnings Conference Call. At this time, all participants are in a listen-only 00:00:10.932 -- 00:00:15.638 mode. After the speaker's presentation, there will be a question and answer session. 00:00:15.638 -- 00:00:20.143 To ask a question during the session, you will need to press star 1 1 on your telephone. 00:00:20.143 -- 00:00:23.467 You will then hear an automated message advising your hand is raised. 00:00:23.467 -- 00:00:26.431 To withdraw your question, please press star 1 1 again. 00:00:26.431 -- 00:00:30.355 Please be advised that today's conference is being recorded. 00:00:30.355 -- 00:00:34.740 I would now like to hand the conference over to your first speaker today, Ryan A.C., 00:00:34.740 -- 00:00:37.023 Senior Vice President of Corporate Affairs. 00:00:37.023 -- 00:00:39.483 Please go ahead. 00:00:41.127 -- 00:00:45.472 Thank you, and welcome everyone to the first quarter 2025 earnings call. 00:00:45.472 -- 00:00:49.977 Joining me on today's call are Dr. Mark Goldsmith, Revolution Medicine's Chairman and 00:00:49.977 -- 00:00:55.324 Chief Executive Officer, Dr. Steve Kelsey, our President of R&D, Dr. 00:00:55.324 -- 00:01:01.152 Wei Lin, our Chief Medical Officer, and Jack Anders, our Chief Financial Officer. 00:01:01.152 -- 00:01:06.059 I'd like to inform you that certain statements we make during this call will be forward-looking. 00:01:06.059 -- 00:01:10.926 Because such statements deal with future events and are subject to many risks and uncertainties, 00:01:10.926 -- 00:01:15.513 actual results may differ materially from those in the forward-looking statements. 00:01:15.513 -- 00:01:19.539 For...